Response of heart rate variability and cardiorespiratory phase synchronization to routine bronchodilator test in patients with asthma

Heart rate variability (HRV) and cardiorespiratory phase synchronization (CRPS) were employed to study the cardio- and respiratory interactions in patients with asthma receiving inhalation of beta2-agonist (Berotec 200 mcg) for routine bronchodilator test. Both time- and frequency-domain parameters...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chih-Hsiang Tsou, Lin-Sen Pon, Jun-Zhi Liang, Yun-Hsiang Chan, Kuan-Jung Chen, Feng-Shiang Cheng, Tsair Kao, Sai-Wei Yang
Format: article
Langue:EN
Publié: Wolters Kluwer Medknow Publications 2021
Sujets:
Accès en ligne:https://doaj.org/article/09366877df9c42948e377e2cfaa60e9b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:Heart rate variability (HRV) and cardiorespiratory phase synchronization (CRPS) were employed to study the cardio- and respiratory interactions in patients with asthma receiving inhalation of beta2-agonist (Berotec 200 mcg) for routine bronchodilator test. Both time- and frequency-domain parameters were used to analyze the HRV. A weighted G-index was introduced to study the quality of the CRPS. The HRV parameters, in both the time and frequency domains, exhibited significant changes pointing to a sympathetic activation of the autonomic balance immediately after the inhalation. On the other hand, the CRPS index barely changed throughout the entire process. This indicates that inhalation of beta2-agonist does not alter the CRPS appreciably, and that the CRPS, in contrast to HRV, is relatively stable in response to the inhalation of beta2-agonist in patients with asthma.